NO20032091L - Blandinger av N-(metyletylaminokarbonyl)-4-(3- metylfenylamino)-3-pyridylsulfonamid og sykliske oligosakkarider - Google Patents

Blandinger av N-(metyletylaminokarbonyl)-4-(3- metylfenylamino)-3-pyridylsulfonamid og sykliske oligosakkarider

Info

Publication number: NO20032091L
Authority: NO; Norway
Prior art keywords: pyridylsulfonamide; methylethylaminocarbonyl; methylphenylamino; mixtures; cyclic oligosaccharides
Prior art date: 2000-11-10

Application number

NO20032091A

Other languages

English (en)

Norwegian (no)

Other versions

NO20032091D0 (no

Inventor

Miljenko Dumic

Darko Filic

Bozena Klepic

Aleksandar Danilovski

Marijan Tudja

Original Assignee

Pliva Pharm & Chem Works

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2000-11-10

Filing date

2003-05-09

Publication date

2003-07-02

2003-05-09 Application filed by Pliva Pharm & Chem Works filed Critical Pliva Pharm & Chem Works

2003-05-09 Publication of NO20032091D0 publication Critical patent/NO20032091D0/no

2003-07-02 Publication of NO20032091L publication Critical patent/NO20032091L/no

Links

-1 cyclic oligosaccharides Chemical class 0.000 title abstract 2
239000000203 mixture Substances 0.000 title abstract 2
229920001542 oligosaccharide Polymers 0.000 title abstract 2
KMYFTLHVDUDUPD-UHFFFAOYSA-N 1-ethyl-1-methyl-3-[4-(3-methylanilino)pyridin-3-yl]sulfonylurea Chemical compound CCN(C)C(=O)NS(=O)(=O)C1=CN=CC=C1NC1=CC=CC(C)=C1 KMYFTLHVDUDUPD-UHFFFAOYSA-N 0.000 title 1
NGBFQHCMQULJNZ-UHFFFAOYSA-N Torsemide Chemical compound CC(C)NC(=O)NS(=O)(=O)C1=CN=CC=C1NC1=CC=CC(C)=C1 NGBFQHCMQULJNZ-UHFFFAOYSA-N 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/716—Glucans
- A61K31/724—Cyclodextrins
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
- A61K47/6949—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes
- A61K47/6951—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes using cyclodextrin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/12—Antidiuretics, e.g. drugs for diabetes insipidus
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Pharmacology & Pharmacy (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Animal Behavior & Ethology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Epidemiology (AREA)
Molecular Biology (AREA)
Nanotechnology (AREA)
Pulmonology (AREA)
Heart & Thoracic Surgery (AREA)
Cardiology (AREA)
Diabetes (AREA)
Ophthalmology & Optometry (AREA)
General Engineering & Computer Science (AREA)
Hematology (AREA)
Biophysics (AREA)
Biotechnology (AREA)
Urology & Nephrology (AREA)
Medical Informatics (AREA)
Crystallography & Structural Chemistry (AREA)
Vascular Medicine (AREA)
Medicinal Preparation (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Saccharide Compounds (AREA)

NO20032091A 2000-11-10 2003-05-09 Blandinger av N-(metyletylaminokarbonyl)-4-(3- metylfenylamino)-3-pyridylsulfonamid og sykliske oligosakkarider NO20032091L (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
HR20000765A HRP20000765A2 (en)	2000-11-10	2000-11-10	Compositions of n-(1-methylethylaminocarbonyl)-4-(3-methylphenylamino)-3-pyridylsulfonamide and cyclic oligosaccharides with increased release
PCT/HR2001/000004 WO2002038186A1 (en)	2000-11-10	2001-01-31	Compositions of n-(methylethylaminocarbonyl)-4-(3-methylphenylamino)-3-pyridylsulfonamide and cyclic oligosaccharides

Publications (2)

Publication Number	Publication Date
NO20032091D0 NO20032091D0 (no)	2003-05-09
NO20032091L true NO20032091L (no)	2003-07-02

Family

ID=10947206

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20032091A NO20032091L (no)	2000-11-10	2003-05-09	Blandinger av N-(metyletylaminokarbonyl)-4-(3- metylfenylamino)-3-pyridylsulfonamid og sykliske oligosakkarider

Country Status (26)

Country	Link
US (1)	US7037928B2 (cs)
EP (1)	EP1347780B1 (cs)
JP (1)	JP2004513155A (cs)
KR (1)	KR20030060929A (cs)
CN (1)	CN1477977A (cs)
AR (1)	AR026815A1 (cs)
AU (1)	AU2001228721A1 (cs)
BG (1)	BG107896A (cs)
BR (1)	BR0115281A (cs)
CA (1)	CA2428179A1 (cs)
CZ (1)	CZ20031490A3 (cs)
DE (1)	DE60125828T2 (cs)
EA (1)	EA005111B1 (cs)
EE (1)	EE200300197A (cs)
GE (1)	GEP20043403B (cs)
HR (1)	HRP20000765A2 (cs)
HU (1)	HUP0400776A2 (cs)
IL (1)	IL155818A0 (cs)
IS (1)	IS6810A (cs)
MX (1)	MXPA03004111A (cs)
NO (1)	NO20032091L (cs)
PL (1)	PL361667A1 (cs)
SK (1)	SK6722003A3 (cs)
WO (1)	WO2002038186A1 (cs)
YU (1)	YU35303A (cs)
ZA (1)	ZA200303601B (cs)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
SI21703A (en) *	2004-01-14	2005-08-31	Lek Farmacevtska Druzba Dd	Inclusion complexes of perindopril, procedure of their preparation, pharmaceutical compositions containing these complexes and their application in treatment of hypertensia
PT1708991E (pt) *	2004-01-22	2007-12-14	Pfizer	Derivados de sulfonamida para o tratamento de doenças
CN100372534C (zh) *	2006-04-20	2008-03-05	南京海辰药业有限公司	托拉塞米冻干制剂及制备方法
JP5469595B2 (ja)	2007-04-13	2014-04-16	ミレニアムファーマシューティカルズ，インコーポレイテッド	第Ｘａ因子阻害薬として作用する化合物との併用抗凝固療法
BR102012009317B1 (pt) *	2012-04-20	2022-05-31	Universidade Federal De Minas Gerais - Ufmg	Processo de preparação de compostos de inclusão envolvendo ciclodextrinas e fármacos, usando um sistema de fluxo contínuo
US9932304B2 (en) *	2015-06-16	2018-04-03	University College Dublin, National University Of Ireland, Dublin	Thromboxane receptor antagonists
ES3041602T3 (en)	2018-12-10	2025-11-13	Sq Innovation Ag	Pharmaceutical compositions of furosemide and uses thereof
US12397005B2 (en)	2019-01-04	2025-08-26	Sq Innovation Ag	Pharmaceutical compositions of torsemide and uses thereof
ES3058386T3 (es)	2019-01-04	2026-03-10	Sq Innovation Ag	Composiciones farmacéuticas de furosemida

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US576511A (en) *		1897-02-02		Georg steinike and friedrich schmidt
DE3529529A1 (de) *	1985-08-17	1987-02-19	Boehringer Mannheim Gmbh	Verfahren zur herstellung einer stabilen modifikation von torasemid
JPH10513634A (ja) *	1995-12-01	1998-12-22	フィリップスエレクトロニクスネムローゼフェンノートシャップ	デジタルコードレス電話システム、無線基地局、並びに無線基地局及びコードレスハンドセットの組合せ
US6828334B2 (en) *	2002-05-23	2004-12-07	Usv Limited	Fenofibrate-cyclodextrin inclusion complexes and their pharmaceutical composition

2000
- 2000-11-10 HR HR20000765A patent/HRP20000765A2/hr not_active Application Discontinuation
2001
- 2001-01-09 AR ARP010100079A patent/AR026815A1/es not_active Application Discontinuation
- 2001-01-31 ZA ZA200303601A patent/ZA200303601B/xx unknown
- 2001-01-31 KR KR10-2003-7006357A patent/KR20030060929A/ko not_active Withdrawn
- 2001-01-31 WO PCT/HR2001/000004 patent/WO2002038186A1/en not_active Ceased
- 2001-01-31 CZ CZ20031490A patent/CZ20031490A3/cs unknown
- 2001-01-31 EA EA200300556A patent/EA005111B1/ru not_active IP Right Cessation
- 2001-01-31 MX MXPA03004111A patent/MXPA03004111A/es unknown
- 2001-01-31 PL PL01361667A patent/PL361667A1/xx unknown
- 2001-01-31 DE DE60125828T patent/DE60125828T2/de not_active Expired - Fee Related
- 2001-01-31 HU HU0400776A patent/HUP0400776A2/hu unknown
- 2001-01-31 US US10/416,303 patent/US7037928B2/en not_active Expired - Fee Related
- 2001-01-31 AU AU2001228721A patent/AU2001228721A1/en not_active Abandoned
- 2001-01-31 EP EP01993478A patent/EP1347780B1/en not_active Expired - Lifetime
- 2001-01-31 GE GE5156A patent/GEP20043403B/en unknown
- 2001-01-31 SK SK672-2003A patent/SK6722003A3/sk unknown
- 2001-01-31 EE EEP200300197A patent/EE200300197A/xx unknown
- 2001-01-31 CA CA002428179A patent/CA2428179A1/en not_active Abandoned
- 2001-01-31 JP JP2002540768A patent/JP2004513155A/ja active Pending
- 2001-01-31 YU YU35303A patent/YU35303A/sh unknown
- 2001-01-31 CN CNA018198309A patent/CN1477977A/zh active Pending
- 2001-01-31 BR BR0115281-5A patent/BR0115281A/pt not_active IP Right Cessation
- 2001-01-31 IL IL15581801A patent/IL155818A0/xx unknown
2003
- 2003-05-08 IS IS6810A patent/IS6810A/is unknown
- 2003-05-09 NO NO20032091A patent/NO20032091L/no not_active Application Discontinuation
- 2003-06-10 BG BG107896A patent/BG107896A/bg unknown

Also Published As

Publication number	Publication date
BG107896A (bg)	2004-01-30
AU2001228721A1 (en)	2002-05-21
KR20030060929A (ko)	2003-07-16
CA2428179A1 (en)	2002-05-16
WO2002038186A1 (en)	2002-05-16
US20040039204A1 (en)	2004-02-26
PL361667A1 (en)	2004-10-04
JP2004513155A (ja)	2004-04-30
YU35303A (sh)	2006-03-03
CN1477977A (zh)	2004-02-25
EA200300556A1 (ru)	2003-08-28
IS6810A (is)	2003-05-08
SK6722003A3 (en)	2003-10-07
HUP0400776A2 (hu)	2004-08-30
EE200300197A (et)	2003-08-15
EP1347780A1 (en)	2003-10-01
EP1347780B1 (en)	2007-01-03
HRP20000765A2 (en)	2002-06-30
EA005111B1 (ru)	2004-10-28
BR0115281A (pt)	2003-07-29
DE60125828T2 (de)	2007-08-16
US7037928B2 (en)	2006-05-02
CZ20031490A3 (cs)	2003-08-13
MXPA03004111A (es)	2004-05-05
IL155818A0 (en)	2003-12-23
GEP20043403B (en)	2004-06-10
NO20032091D0 (no)	2003-05-09
ZA200303601B (en)	2004-07-19
AR026815A1 (es)	2003-02-26
DE60125828D1 (de)	2007-02-15

Legal Events

Date	Code	Title	Description
2006-08-28	FC2A	Withdrawal, rejection or dismissal of laid open patent application

Publication	Publication Date	Title
NO20032733L (no)	2003-08-14	Difenylazetidinonderivater, fremgangsmåte for deres fremstilling, legemidler som inneholder disse forbindelsene og deres anvendelse
DK1320531T3 (da)	2011-01-03	Bicyclo-pyrazoler, der er aktive som kinase inhibitorer, fremgangsmåde til fremstilling deraf og farmaceutiske sammensætninger, der indeholder disse
NO20042161L (no)	2004-08-17	Inhibitorer av 11-beta-hydroksysteroid dehydrogenase type 1
DK1202965T3 (da)	2005-02-14	Indolderivater, fremgangsmåde til fremstilling deraf, farmaceutiske præparater indeholdende disse og deres medicinske anvendelse
NO20025821L (no)	2003-02-04	2-aminokarbonyl-9H-purinderivater
DK1294682T3 (da)	2004-08-02	Acylphenylurinstofderivater, fremgangsmåde til deres fremstilling og deres anvendelse som lægemiddel
NO20035298D0 (no)	2003-11-28	CDK-inhiberende pyrimider, deres fremstilling og deres anvendelse som legemidler
NO20024175L (no)	2002-10-29	Azetidinderivater, deres fremstilling og farmasöytiske preparater inneholdende forbindelsene
NO20054905L (no)	2006-01-25	2-acylamino-4-fenyltiazolderivater, fremgangsmate for deres fremstilling og anvendelse av de samme som i terapeutika
NO20002486D0 (no)	2000-05-12	Sykliske aminderivater og deres anvendelse som legemidler
NO20005224L (no)	2000-12-18	BTK inhibitorer og fremgangsmåter for deres identifikasjon og anvendelse
NO20024742D0 (no)	2002-10-02	Heterocykliske forbindelser, deres fremstilling og anvendelse
NO20045486L (no)	2005-02-02	Nye forbindelser og deres anvendelse
NO20010028L (no)	2001-01-03	Benzimidazoler, deres fremstilling og anvendelse som legemidler
DK1557415T3 (da)	2012-09-17	Heterocykliske forbindelser og antitumorlægemidler indeholdende samme som den aktive ingrediens
DK1445252T3 (da)	2006-06-19	Sulfonamid-derivater, deres fremstilling og anvendelse som medikamenter
DK1517890T3 (da)	2008-11-10	Kationisk substituerede diphenylazetidinoner, fremgangsmåde til deres fremstilling, lægemidler indeholdende disse forbindelser og deres anvendelse
DE60209929D1 (de)	2006-05-11	Succinate des 5,8,14-triazatetracycloä10.3.1.0 2,11 .0 4,9 ü-hexadeca-2(11),3,5,7,9,-pentaens und pharmazeutische zusammensetzungen
ECSP055701A (es)	2005-05-30	Nuevos derivados de pirimidinamida y el uso de los mismos
NO20040702L (no)	2004-05-19	Kombinerte preparater som inneholder 1,4-benzotiepin-1,1-dioksidderivater og andre aktive substanser og anvendelsen derav
DK1674456T3 (da)	2008-10-27	Nye 1,4-benzothiazepin-1,1-dioxid-derivater med forbedrede egenskaber, fremgangsmåde til deres fremstilling, lægemidler indeholdende disse forbindelser og deres anvendelse
DK1322158T3 (da)	2012-11-19	Farmaceutiske præparater med langvarig frigivelse, som indeholder metformin, og fremgangsmåde til fremstilling deraf
NO20032091L (no)	2003-07-02	Blandinger av N-(metyletylaminokarbonyl)-4-(3- metylfenylamino)-3-pyridylsulfonamid og sykliske oligosakkarider
DE60121587D1 (de)	2006-08-31	Zyklische gmp-spezifische phosphodiesteraseinhibitoren
NO20073071L (no)	2007-06-15	Benzotiazolformuleringer og anvendelse av disse